These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 4789981

  • 1. [Plasma aldosterone and plasma renin activity during hemodialysis].
    Vetter W, Zaruba K, Armbruster H, Beckerhoff R, Strebel U, Siegenthaler W.
    Verh Dtsch Ges Inn Med; 1973; 79():763-7. PubMed ID: 4789981
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Mechanisms of hypertension in patients with terminal kidney failure on programmed hemodialysis].
    Krimkevich EI, Petrun' NM, Baran EIa, Kutsaĭ NN, Khomenko NV.
    Ter Arkh; 1986; 58(8):81-4. PubMed ID: 3020729
    [Abstract] [Full Text] [Related]

  • 4. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D, Kalevrosoglou I, Karamouzis M, Geropoulou E, Kabouris H, Tourkantonis A.
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [Abstract] [Full Text] [Related]

  • 5. [Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure].
    Hory B, Henriet MT.
    Nephrologie; 1983 Feb; 4(4-5):229-30. PubMed ID: 6320023
    [Abstract] [Full Text] [Related]

  • 6. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P, Fardella C, Oestreicher E, Gac H, Mosso L, Soto J, Foradori A, Claverie X, Ahuad J, Montero J.
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [Abstract] [Full Text] [Related]

  • 7. Control of plasma aldosterone during hemodialysis in patients with terminal renal failure.
    Vetter W, Záruba K, Armbruster H, Beckerhoff R, Nussberger J, Furrer J, Fontana A, Siegenthaler W.
    Nephron; 1977 Sep; 18(2):114-23. PubMed ID: 857174
    [Abstract] [Full Text] [Related]

  • 8. Saline suppression of plasma aldosterone and plasma renin activity in hypertension.
    Kem DC, Mayes D, Weinberger M, Nugent CA.
    Ariz Med; 1971 Apr; 28(4):264-6. PubMed ID: 5572938
    [No Abstract] [Full Text] [Related]

  • 9. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
    Papadimitriou M, Vyzantiadis A, Milionis A, Memmos D, Metaxas P.
    Life Support Syst; 1983 Apr; 1(3):197-205. PubMed ID: 6433115
    [Abstract] [Full Text] [Related]

  • 10. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
    Lifshits NL, Kutyrina IM.
    Ter Arkh; 1999 Apr; 71(6):64-7. PubMed ID: 10420461
    [Abstract] [Full Text] [Related]

  • 11. Reversibility of hyporeninemia and hypoaldosteronemia in chronic hemodialysis patients by correction of fluid excess.
    Krause JZ, Matarese RA, Zabetakis PM, Michelis MF.
    J Lab Clin Med; 1980 Oct; 96(4):734-42. PubMed ID: 6999102
    [No Abstract] [Full Text] [Related]

  • 12. Plasma renin activity, aldosterone and cortisol levels during physical exercise in essential hypertension.
    Ignatowska-Switalska H, Wocial B, Skórka B, Chodakowska J, Nazar K, Chwalbińska-Moneta J.
    Acta Physiol Pol; 1980 Oct; 31(6):631-5. PubMed ID: 7018172
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of long-term hemodialysis on renin activity, aldosterone, cortisol, serum potassium, serum sodium and blood pressure].
    Vetter W, Záruba K, Studer A, Grimm J, Kopp HG, Kuhlmann U, Tuma J, Siebenschein R, Furrer J, Siegenthaler W.
    Verh Dtsch Ges Inn Med; 1978 Oct; (84):832-4. PubMed ID: 742136
    [No Abstract] [Full Text] [Related]

  • 15. Plasma aldosterone in hypertensive patients on chronic hemodialysis: distribution, determinants and impact on survival.
    Kohagura K, Higashiuesato Y, Ishiki T, Yoshi S, Ohya Y, Iseki K, Takishita S.
    Hypertens Res; 2006 Aug; 29(8):597-604. PubMed ID: 17137215
    [Abstract] [Full Text] [Related]

  • 16. [Activity of plasma renin and plasma aldosterone in terminal renal failure].
    Vetter W, Záruba K, Armbruster H, Beckerhoff R, Reck G, Siegenthaler W.
    Schweiz Med Wochenschr; 1974 Dec 07; 104(49):1799-801. PubMed ID: 4456599
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.